Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Alger

Alger Health Sciences Fund Alger Health Sciences Fund Class A (AHSAX)

Ticker AHSAX · Since 2002-05-01 · · Holdings as of Jul 31, 2026

Expense ratio
1.17%$117/yr per $10k
5-yr return
−3.0%annualized
1-yr return
+4.4%as of Dec 2025
Net assets
$75.4Mall share classes
Holdings
55

Bottom line

Is AHSAX a good fund? The bottom line

AHSAX is a share class of Alger Health Sciences Fund, a managed health care sector mutual fund from Alger.

Annual fees run 1.17% — about $117 a year on every $10,000 invested, more expensive than 67% of health care sector funds we track.

It returned +4.4% over one year, −3.0% a year over five years, +6.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $75.4 million in net assets and 55 holdings, its largest position is Dreyfus Treasury Obligations Cash Management (6.5%) and the top 10 make up 42.3% of the portfolio.

This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.

What to watch

  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 5.25%
  • 12b-1 marketing fee of 0.25% a year
  • High turnover (289% a year) can mean more taxable distributions

Updated Nov 19, 2026

What AHSAX invests in

Alger Health Sciences Fund seeks long-term capital appreciation.

The Manager believes companies undergoing Positive Dynamic Change offer the best opportunities. Positive Dynamic Change refers to companies realizing High Unit Volume Growth or companies undergoing Positive Lifecycle Change. High Unit Volume Growth companies are traditional growth companies experiencing, for example, rapidly growing demand or market dominance. Positive Lifecycle Change companies are, for example, companies benefitting from new regulations, a new product innovation or new management. Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. Equity securities include common or preferred stocks that are listed on U.S. or foreign exchanges. A company will be considered to be engaged in the health…

From the fund's prospectus (filed Mar 5, 2026).

AHSAX performance

Fund calendar-year total returns, 2016–2025 2016: −3.3%; 2017: +37.2%; 2018: +5.8%; 2019: +22.0%; 2020: +31.0%; 2021: +2.5%; 2022: −17.0%; 2023: −4.3%; 2024: +1.2%; 2025: +10.2% −3% 2016 +37% 2017 +6% 2018 +22% 2019 +31% 2020 +3% 2021 −17% 2022 −4% 2023 +1% 2024 +10% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
AHSAX+4.4%−3.0%+6.8%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full AHSAX performance history →

What AHSAX costs

On a $10,000 investment, AHSAX's 1.17% expense ratio costs about $117 a year. The prospectus estimates $1,871 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full AHSAX fee table →

AHSAX top 10 holdings

#Holding% of fund
1Dreyfus Treasury Obligations Cash Management6.51%
2Impulse Dynamics Ireland4.27%
3Merck & Company Inc MRK4.18%
4Welltower Inc WELL4.12%
5Johnson & Johnson JNJ4.06%
6Thermo Fisher Scientific Inc TMO4.00%
7Bruker Corp BRKR3.98%
8Illumina Inc ILMN3.95%
9Cvs Health Corp CVS3.67%
10Unitedhealth Group Inc UNH3.61%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 42.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to AHSAX

More funds like AHSAX →

AHSAX FAQ

What is the expense ratio of AHSAX?
AHSAX's expense ratio is 1.17%, which works out to about $117 a year for every $10,000 invested. The prospectus estimates total costs of $1,871 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is AHSAX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; front-end sales load up to 5.25%; 12b-1 marketing fee of 0.25% a year; high turnover (289% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does AHSAX hold?
AHSAX's largest holdings are Dreyfus Treasury Obligations Cash Management (6.5%), Impulse Dynamics Ireland (4.3%), Merck & Company Inc (4.2%), Welltower Inc (4.1%), Johnson & Johnson (4.1%). It holds 55 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is AHSAX's 5-year return?
AHSAX returned −3.0% a year over the five years ending Dec 31, 2025, and +6.8% a year over ten years. Past performance does not guarantee future results.
Does AHSAX have a sales load?
Yes. AHSAX has a maximum front-end sales charge of 5.25%.
Who manages AHSAX?
AHSAX is offered by Alger through Alger Funds.